WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Thursday, September 1, 2016

New test for Parkinson’s disease moves a step closer

  • 1 September 2016


Positive RT-QuIC signal is only detected in the CSF of patients with pathologically confirmed alpha-synucleinopathy. ThT=thioflavine T; RFU= relative fluorescence unit

Scientists from the Oxford Parkinson’s Disease Centre (OPDC) and the Edinburgh Prion Unit have developed a new diagnostic test for Parkinson’s disease. The test measures the 'stickiness' of a particular protein in the cerebrospinal fluid.

This protein, known as alpha-synuclein, forms sticky clumps known as Lewy bodies within the brain cells of patients with Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). There is currently no definitive test that allows doctors to determine if someone has Parkinson's or related disorders, especially at the early stage. So at present the diagnosis is based purely on clinical symptoms and can only be confirmed with a post-mortem examination of the brain. 

These are hugely promising results and we are extending the analysis to a larger cohort of OPDC Discovery samples. We are particularly keen to understand how early these changes can be detected and whether our assay could be used as a predictive test. We also hope to refine our technique to detect alpha-synuclein aggregation in the nasal mucosa collected through a safer and less invasive brushing procedure compared to lumbar puncture required for the CSF collection.
- Laura Parkkinen

Previous efforts to develop a test for alpha-synuclein have produced inconsistent results because the protein is also found in the brain and cerebrospinal fluid (CSF) of healthy subjects. It is only when the protein clumps together that it causes problems. 

An extremely sensitive technology called real-time quaking-induced conversion (RT-QuIC) allows the measurement of stickiness of proteins; this approach has already been used to detect the CSF prion protein in Creutzfeldt-Jakob disease. Dr Laura Parkkinen and her team used this technology in brain material derived from the Oxford Brain Bank and CSF samples from the OPDC Discovery cohort. They were able to detect 'sticky' alpha-synuclein protein in the patients with PD and DLB with sensitivities of 95% and 92%, respectively, and with an overall specificity of 100% when compared to Alzheimer’s and controls.

Interestingly, few patients known to be at risk of developing PD/DLB (i.e. patients with REM sleep behaviour disorder) had a positive result. This suggests that this test could potentially detect patients before their motor and/or cognitive symptoms appear and thus allow the initiation of early treatment that could slow or even stop the disease.

https://www.ndcn.ox.ac.uk/news/new-diagnostic-test-for-parkinson2019s-disease-moves-a-step-closer

No comments:

Post a Comment